Tumor ROIs of short-term survivors revealed a high expression of molecules correlated with immune suppression such as PD-1, PD-L1, CTLA4, LAG3, FoxP3, and CD25 compared to long-term survivors (Table 1). This evidence concerns the gene CD274 and neoplasm.